TheFly.com
CDXC
ChromaDex
$
()
ChromaDex price target raised by $1.75 at Roth MKM, here's why
ChromaDex price target raised by $1 at H.C. Wainwright, here's why
ChromaDex sees FY24 revenue growth higher than FY23, consensus $95.78M
ChromaDex reports Q4 EPS (7c), consensus (3c)
ChromaDex, Neurohacker Collective partner for Qualia NAD+
ChromaDex shares results of high dose Niagen and mild improvements in PD
ChromaDex: Study shows Niagen supplementation increases whole blood NAD+ levels
ChromaDex price target lowered to $6 from $6.60 at Ladenburg
ChromaDex sees FY23 revenue growth up 14%-16%
ChromaDex reports Q3 EPS (1c), consensus (3c)
ChromaDex reports Q3 EPS 91c), consensus (3c)
ChromaDex reports Q2 EPS (3c), consensus (4c)
ChromaDex: Abstracts showcase importance of NAD+ with NR supplementation in POAG
Copyright ©1998-2024 Thefly.com LLC
